Evidence map›Paper›PMID 29078356›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Cyclic activation of endplate acetylcholine receptors.

Tapan K Nayak, Anthony Auerbach

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Pathways for nicotinic receptor desensitization.The Journal of general physiology · 2020
    Article
  9. The Glycine Receptor Allosteric Ligands Library (GRALL).Bioinformatics (Oxford, England) · 2020
    Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tapan K NayakDepartment of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY 14214.
Anthony AuerbachDepartment of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY 14214 auerbach.anthony@gmail.com.
University at Buffalo, State University of New York · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Engineering a Transmitter Binding SiteR01NS064969 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 2009 to 2018
$4.1M
NCATS NIH HHS UL1 TR001412NINDS NIH HHS R01 NS064969
6 · The paper itself

Abstract

Agonists turn on receptors because they have a higher affinity for active versus resting conformations of the protein. Activation can occur by either of two pathways that connect to form a cycle: Agonists bind to resting receptors that then become active, or resting receptors activate and then bind agonists. We used mutations to construct endplate acetylcholine receptors (AChRs) having only one functional neurotransmitter-binding site and single-channel electrophysiology to measure independently binding constants for four different agonists, to both resting and active conformations of each site. For all agonists and sites, the total free energy change in each pathway was the same, confirming the activation cycle without external energy. Other results show that (

Indexed as

AcetylcholineAnimalsBinding SitesCholinergic AgonistsEnzyme ActivationMiceModels, BiologicalNeurotransmitter AgentsNicotinic AgonistsPatch-Clamp TechniquesProtein BindingReceptors, CholinergicReceptors, NicotinicSignal TransductionAcetylcholineCholinergic AgonistsNeurotransmitter AgentsNicotinic AgonistsReceptors, CholinergicReceptors, Nicotinicagonist bindingallosteric activationion channelnicotinic

Identifiers

PMID29078356
PMCPMC5692566
OpenAlexW2765858904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.